These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 22846397)
61. Transcript analysis of the c-vac region and differential synthesis of the two regulatory gas vesicle proteins GvpD and GvpE in Halobacterium salinarium PHH4. Krüger K; Pfeifer F J Bacteriol; 1996 Jul; 178(14):4012-9. PubMed ID: 8763925 [TBL] [Abstract][Full Text] [Related]
62. Chlamydia abortus OmcB protein is essential for adhesion to host cells. Liang L; Liu D; Li Z; Zhou J; Tong D J Basic Microbiol; 2021 Dec; 61(12):1145-1152. PubMed ID: 34695236 [TBL] [Abstract][Full Text] [Related]
64. Long-term stability of a vaccine formulated with the amphipol-trapped major outer membrane protein from Chlamydia trachomatis. Feinstein HE; Tifrea D; Sun G; Popot JL; de la Maza LM; Cocco MJ J Membr Biol; 2014 Oct; 247(9-10):1053-65. PubMed ID: 24942817 [TBL] [Abstract][Full Text] [Related]
65. Bioengineering of Halobacterium sp. NRC-1 gas vesicle nanoparticles with GvpC fusion protein produced in E. coli. Kim JM; Kim YS; Kim YR; Choi MJ; DasSarma P; DasSarma S Appl Microbiol Biotechnol; 2022 Mar; 106(5-6):2043-2052. PubMed ID: 35230496 [TBL] [Abstract][Full Text] [Related]
66. Cell-free Scaled Production and Adjuvant Addition to a Recombinant Major Outer Membrane Protein from Chlamydia muridarum for Vaccine Development. Gilmore SF; He W; Evans AC; Tifrea DF; Pal S; Segelke B; Peters SKG; Vannest BD; Fischer NO; Rasley A; de la Maza LM; Coleman MA J Vis Exp; 2022 Mar; (181):. PubMed ID: 35377358 [TBL] [Abstract][Full Text] [Related]
67. Stability and antigenicity of Chlamydia muridarum major outer membrane protein antigen at body temperature. Russell FA; Trim L; Bryan E; Fisher MA; Leahy D; Harris JM; Hutmacher D; Dargaville TR; Beagley KW Vaccine; 2024 Jun; ():. PubMed ID: 38897891 [TBL] [Abstract][Full Text] [Related]
68. Seventy Years of Phillips S; Quigley BL; Timms P Front Microbiol; 2019; 10():70. PubMed ID: 30766521 [No Abstract] [Full Text] [Related]
69. Gas vesicles are strengthened by the outer-surface protein, GvpC. Hayes PK; Buchholz B; Walsby AE Arch Microbiol; 1992; 157(3):229-34. PubMed ID: 1510555 [TBL] [Abstract][Full Text] [Related]
70. The Therapeutic Benefit of Bacterial Membrane Vesicles. Bitto NJ; Kaparakis-Liaskos M Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28621731 [TBL] [Abstract][Full Text] [Related]
76. Microbial gas vesicles as nanotechnology tools: exploiting intracellular organelles for translational utility in biotechnology, medicine and the environment. Hill AM; Salmond GPC Microbiology (Reading); 2020 Jun; 166(6):501-509. PubMed ID: 32324529 [TBL] [Abstract][Full Text] [Related]
77. Recent Advances in the Study of Gas Vesicle Proteins and Application of Gas Vesicles in Biomedical Research. Pfeifer F Life (Basel); 2022 Sep; 12(9):. PubMed ID: 36143491 [TBL] [Abstract][Full Text] [Related]
78. Advances in the application of gas vesicles in medical imaging and disease treatment. Feng R; Lan J; Goh MC; Du M; Chen Z J Biol Eng; 2024 Jul; 18(1):41. PubMed ID: 39044273 [TBL] [Abstract][Full Text] [Related]
79. Bioengineering novel floating nanoparticles for protein and drug delivery. DasSarma P; Karan R; Kim JM; Pecher W; DasSarma S Mater Today Proc; 2016; 3(2):206-210. PubMed ID: 27158595 [TBL] [Abstract][Full Text] [Related]
80. Correction to: Bioengineering of Halobacterium sp. NRC‑1 gas vesicle nanoparticles with GvpC fusion protein produced in E. coli. Kim JM; Kim YS; Kim YR; Choi MJ; DasSarma P; DasSarma S Appl Microbiol Biotechnol; 2022 Apr; 106(8):3319. PubMed ID: 35435460 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]